Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02440464
Title Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Heart, Lung, and Blood Institute (NHLBI)
Indications

multiple myeloma

Therapies

Methotrexate + Tacrolimus

Ixazomib

Fludarabine + Melphalan

Bortezomib

Age Groups: adult
Covered Countries USA


No variant requirements are available.